Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax

Total 64 results found. Search for [ Lipitor ]

Results 1 to 21 of 64
PB Jayakumar
May 8, 2021
The two m-RNA technology based COVID-19 vaccines are set to shatter the record of Pfizer's Lipitor in terms of highest sales in a year.

E Kumar Sharma
New Delhi, November 25, 2019
Rajiv Malik, President, Mylan, speaks about the impact the deal will have on India operations, the challenges in generic drugs and the role that China will play

E Kumar Sharma
September 5, 2019
Even as smaller Indian companies are looking to grow their business in the US market, the larger focus is on leading pharma companies because the top 20 of them contribute 75 per cent to total pharma exports from India

March 7, 2019

Gina Krishnan
New Delhi, February 6, 2018
With the Delhi High Court's verdict, Daiichi Sankyo has scored a victory against former Ranbaxy promoters. But it won't end there.

Joe C Mathew
May 6, 2016
Breach of faith, dreams turned sour and a $5.35 billion hole in the pocket. That, in substance, was the Japanese pharma major Daiichi-Sankyo's failed India sojourn that began in June, 2008 and packed up in April, 2014.

Natalie Grover
Bengaluru, October 29, 2015
The Wall Street Journal said that the deal could be the biggest merger in the healthcare industry in already busy year.

PB Jayakumar
March 26, 2015
Soon Ranbaxy Laboratories will cease to exist as the company is merging with Sun Pharmaceutical Industries.

New Delhi, February 5, 2015
This is Pfizer's biggest acquisition after its failed $117 billion takeover bid for UK-based pharmaceuticals firm AstraZeneca in May last year.

Natalie Grover and Zeba Siddiqui
Mumbai, September 16, 2014
Epirus Biopharmaceuticals said that the domestic drug regulator has approved its copy of a top-selling arthritis treatment, paving the way for its launch in the India early next year.

Jonathan Stempel and Brendan Pierson
September 13, 2014
U.S. District Judge Peter Sheridan in Trenton, New Jersey, ruled that the plaintiffs, retailers and distribution companies that bought Lipitor directly from Pfizer, failed to plead their case with enough detail.

New York, May 27, 2014
US drug major Pfizer on Monday shelved its $117 billion takeover bid of AstraZenaca on the day of expiry of the offer as the British pharmaceutical company remained firm in opposing the deal.

Ransdell Pierson and Bill Berkrot
New York, May 6, 2014
Regardless of whether the deal arises from friendly negotiations or a hostile approach, it is likely to end on good terms if successfully completed, Pfizer Chief Executive Ian Read said.

New Delhi, May 2, 2014
This is the third time that AstraZeneca has rejected Pfizer's offer and the second in less than a week. Pfizer, the New York-headquartered maker of cholesterol drug Lipitor and Viagra, had made an offer of $100 billion earlier.

New Delhi, April 7, 2014
The combination of Sun Pharma and Ranbaxy creates the fifth-largest specialty generics company in the world and the largest pharmaceutical company in India.

Sumeet Chatterjee and Ben Hirschler
Mumbai/London, March 12, 2014
Ranbaxy Laboratories Ltd is in talks with at least two companies on sourcing ingredients for a generic version of AstraZeneca Plc's heartburn drug Nexium, a source said, to ensure the pills can be sold in the United States.

Mumbai, March 10, 2014
Shares in Ranbaxy Laboratories fell after the drug maker recalled more than 64000 bottles of the generic version of a cholesterol-lowering drug in the United States after doseage mix-up was detected.

March 8, 2014
Drug maker Ranbaxy Laboratories Ltd has recalled more than 64,000 bottles of the generic versions of its cholesterol-lowering drug in the United States due to reports of a dose mix-up, US regulators said.

Karen Freifeld and Chris Peters
Bangalore/New York, February 19, 2014
Under the terms of the settlement, the two generic drug makers will end a 2010 agreement of not challenging each other's rights to sell certain drugs exclusively in the United States.

E. Kumar Sharma
December 7, 2013
There are more than a dozen drugs in important cancer treatment areas that are not available in India. The new drug flow into India has slowed down significantly and it is a matter of concern for oncologists and cancer patients.

PAGES 1 OF 4  1234